Bernardo H. L. Goulart, MD
Seattle Cancer Care Alliance
University of Washington School of Medicine
Fred Hutchinson Cancer Research Center
Thoracic, head and neck
Why did you choose to be an oncologist?
Specialties and clinical expertise
The branch of medicine a provider practices and their areas of focus
Most of my research involves studying the outcomes and pharmacoeconomics of cancer therapies. We analyze treatments in real-world settings, comparing their impact on survival and costs. I also design and conduct studies that assess the quality of cancer treatments delivered nationwide and do economic modeling of the cost-effectiveness of cancer therapies and predictive genomic tests in lung cancer — including EGFR and ALK mutation testing.
I treat patients with a range of head and neck cancers. The challenge is to provide innovative and effective therapies that are also affordable. My hopes are that molecularly targeted treatments will continue to advance and we will develop agents that are much more effective against each subtype of cancer. That means we’ll be better able to tailor treatment to you in particular while sparing you from the potential toxic effects, as well as costs, of ineffective or marginally effective therapies.
What role can patients play in getting great care?
Federal University of Rio de Janeiro
University of Washington
Federal University of Rio de Janeiro, Internal Medicine; Brazilian National Cancer Institute, Medical Oncology
University of Washington, Medical Oncology
Medical Oncology, 2012; General Internal Medicine, 2008, American Board of Internal Medicine
Fellowship, Massachusetts General Hospital, Outcomes Research